Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
06/1998
06/17/1998EP0847240A1 Novel embolizing compositions
06/17/1998EP0636142B1 Lactam peptides having hle inhibiting activity
06/17/1998EP0635003B1 Perhydroisoindole derivatives as p substance antagonists
06/17/1998CN1185156A Novel substituted tetrahydropyrano £3, 2-d| oxazolones, the prodn. and pharmaceutical use thereof
06/17/1998CN1185106A Use of carbazole compounds for treating congestive heart failure
06/17/1998CN1184664A Emulsion for lowering blood-lipid, and method for preparing same
06/17/1998CN1038751C Cyclopeptides
06/16/1998US5767293 Antitumor
06/16/1998US5767274 Treating tumors or restenosis
06/16/1998US5767268 Treatment of disorders characterized by excessive or destructive proliferation of smooth muscle cells
06/16/1998US5767262 Isolated dna comprising sequence encoding smooth muscle cell lim polypeptide
06/16/1998US5767241 Soluble form of GMP-140
06/16/1998US5767160 Method and formulation of stimulating nitric oxide synthesis
06/16/1998US5767159 Improving the capacity of muscles for work and shortening the time for recovery after exercise or various therapies, e.g.postoperative surgery, respiratory disorders
06/16/1998US5767116 Bicyclic aromatic compounds as therapeutic agents
06/16/1998US5767115 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
06/16/1998US5767088 Useful for treating pain, inflammation, smooth muscle contraction and inducing vasodilation
06/16/1998US5766940 Plasmid and plasmid vector
06/16/1998US5766886 Modified antibody variable domains
06/16/1998US5766838 Manual quantitating the number of leukocyte binding tissue cell over a defind are of tissue sample section
06/16/1998US5766610 Useful for treatment of mammalian skin and hair, rheumatism, resipiratory system disorder, cardiovascular and vision disorders
06/16/1998CA2224885A1 Sulfonamide-substituted compounds, processes for their preparation, their use as a medicament or diagnostic, and pharmaceutical preparations comprising them
06/16/1998CA2165779C Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
06/16/1998CA2132831C Hydrazide derivatives of 3,4-dihydro-2h-1-benzopyrans
06/16/1998CA2065965C Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a beta-adrenergic antagonist
06/13/1998CA2219613A1 Crystalline form of the doxazosin mesylate and process for its production
06/11/1998WO1998024916A1 Novel calpaines, production and use thereof
06/11/1998WO1998024914A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
06/11/1998WO1998024902A1 Adaptor protein frs2 and related products and methods
06/11/1998WO1998024892A1 Ve-cadherin promoter and its uses
06/11/1998WO1998024809A1 Peptides agonists of bradykinine b2 receptor
06/11/1998WO1998024805A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
06/11/1998WO1998024790A1 1,4-diazabicyclo [2.2.2] oct-2-ylmethyl derivatives, their preparation and therapeutic application
06/11/1998WO1998024784A1 Substituted sulfonic acid n-[(aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds
06/11/1998WO1998024782A2 Substituted pyrimidine compounds and their use
06/11/1998WO1998024780A2 Substituted pyrimidinone and pyridinone compounds and their use
06/11/1998WO1998024771A1 Benzamide derivatives having a vasopressin antagonistic activity
06/11/1998WO1998024766A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
06/11/1998WO1998024762A1 Vitamin d3 derivatives
06/11/1998WO1998024482A2 Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them
06/11/1998WO1998024447A1 Use of nk-1 receptor antagonists for treating cognitive disorders
06/11/1998WO1998024437A1 Pyrazoles as human non-pancreatic secretory phospholipase a2 inhibitors
06/11/1998WO1998024430A1 Pharmaceutical compositions containing n-sulphonyl indolin derivatives
06/11/1998WO1998024427A2 Compositions and methods for treating or preventing inflammatory diseases
06/11/1998CA2607067A1 Compositions and methods for treating or preventing inflammatory diseases
06/11/1998CA2274304A1 Novel calpaines, production and use thereof
06/11/1998CA2274249A1 Inhibitors of interleukin-1.beta. converting enzyme
06/11/1998CA2274145A1 Adaptor protein frs2 and related products and methods
06/11/1998CA2274048A1 Pyrazoles as human non-pancreatic secretory phospholipase a2 inhibitors
06/11/1998CA2274011A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
06/11/1998CA2273990A1 Pharmaceutical compositions containing n-sulphonyl indolin derivatives
06/11/1998CA2273853A1 Use of nk-1 receptor antagonists for treating cognitive disorders
06/11/1998CA2273190A1 Peptides agonists of bradykinine b2 receptor
06/11/1998CA2272994A1 Ve-cadherin promoter and its uses
06/11/1998CA2272148A1 Vitamin d3 derivatives
06/11/1998CA2271072A1 1,4-diazabicyclo [2.2.2] oct-2-ylmethyl derivatives, their preparation and therapeutic application
06/11/1998CA2245699A1 Substituted sulfonic acid n-¬(aminoiminomethyl)phenylalkyl}-azaheterocyclamide compounds
06/11/1998CA2224131A1 Novel human 11 cb splice variant
06/10/1998EP0846763A2 A protein phosphatase 1 binding protein, R5
06/10/1998EP0846694A1 Morphinan derivative and its pharmaceutical applications
06/10/1998EP0846688A1 New imidazoline derivatives having affinity for the imidazoline receptor
06/10/1998EP0846687A1 Pyrazoles as human non-pancreatic secretory phospholipase A2 inhibitors
06/10/1998EP0846685A1 3-Hydroxypyridine-2-carboxylic acid amide esters, their preparation and their use as medicaments
06/10/1998EP0846464A2 Use of glycogen phosphorylase inhibitor for reducing non-cardiac tissue damage resulting from ischemia
06/10/1998EP0846116A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
06/10/1998EP0846108A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists
06/10/1998EP0845992A1 Method of promoting angiogenesis
06/10/1998EP0845986A1 Pharmaceutical composition for treating cardiovascular diseases containing 3-(2,2,2-trimethylhydrazinium) propionate and gamma-butyrobetaine
06/10/1998EP0831817A4 Antigen-processing cell-targeted conjugates
06/10/1998EP0710113B1 Preparation for improving the blood supply containing hard magnetic particles
06/10/1998EP0674508B1 4-guanidinobutyramide for improving blood circulation
06/10/1998DE19652374A1 Verwendung von Endothelin-Konjugaten in der Therapie, neue Endothelin-Konjugate, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung Use of endothelin-conjugates in therapy, new endothelin conjugates, compositions comprising them, and to processes for their preparation
06/10/1998DE19650975A1 Neue heterocyclisch substituierte Benzamide und deren Anwendung New heterocyclic-substituted benzamides and their application
06/10/1998CN1184483A Fucopeptides
06/10/1998CN1184470A Thienyl-, Furyl-, Pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
06/10/1998CN1184104A 3 -hydroxy -pyridine -2 -carboxylic amide ester, and its preparation and its application as medicine
06/10/1998CN1183960A Controlled release pharmaceutical compositions for oral administration containing nifedipine as active substance
06/10/1998CN1038680C Dihydronaphtho £1, 2-b| pyrane derivative and its producing process and use
06/09/1998US5763621 Reaction of acid compound with hydroxylamine compound or amidation of acid
06/09/1998US5763614 1,4-dihydropyridine derivatives and methods of producing the same
06/09/1998US5763569 Polypeptides as calcium receptors to generate antibodies
06/09/1998US5763567 Human amino acid sequences which can bind to and/or neutralize heparin
06/09/1998US5763496 Selected from catechols and ortho-methoxyphenols
06/09/1998US5763489 Naphthalene derivatives as prostaglandin I2 agonsists
06/09/1998US5763487 Skin disorders, cardiovascular disorders and cosmetics
06/09/1998US5763458 1-phenylalkanone 5-HT4 receptor ligands
06/09/1998US5763220 Human apoptosis-related calcium-binding protein
06/09/1998US5762952 Transdermal delivery of active drugs
06/05/1998CA2223317A1 Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
06/04/1998WO1998023619A1 Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
06/04/1998WO1998023611A1 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023610A1 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023609A1 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023608A1 Novel integrin receptor antagonists
06/04/1998WO1998023603A1 Dimesylate salts of neuropeptide y ligands
06/04/1998WO1998023596A1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023591A1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023581A1 Benzamidoaldehydes and their use as cysteine protease inhibitors
06/04/1998WO1998023565A2 Aminoguanidines and alkoxyguanidines as protease inhibitors
06/04/1998WO1998023299A2 Radiolabeled dna oligonucleotide, method of preparation and therapeutic uses thereof